Inogen, Inc. (INGN): Price-to-Revenue Coefficient

Symbol and logo of brand Inogen Medical (INGN)

Inogen, Inc. (INGN) is combating pricing pressure from competitors by implementing service subscriptions. The price-to-sales trend reflects market expectations, where 0.40 describes the current status of the metric. Business growth relies on partnerships with pulmonologists and distributors. Management is currently restructuring processes to restore margins, aiming to prove the effectiveness of internal cost controls.

INGN: Inogen Inc Price-to-Revenue Ratio 07/04/2022 - 11/13/2026

Analytical breakdowns for Inogen, Inc. (INGN)

- stock value and consensus price forecast:
Stock Price inogen.com|INGN - Price Target Chart
- stock exchange capitalization data:
Market Capitalization Inogen Medical|INGN - Real Price to Acquire Entire Company
- company book value details:
Accounting Value of a Share Inogen, Inc.|INGN - Company Book Value|Market Cap to Net Assets Ratio inogen.com|INGN - Company Total Assets
- business debt structure and liquidity details:
Debt to Capital Inogen, Inc.|INGN - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio inogen.com|INGN - Company Aggregate Debts|Debts to Net Assets Inogen Medical|INGN - Company Long-Term Debts|Company Current Liabilities Inogen, Inc.|Quick Ratio inogen.com
- earnings and valuation multiples information:
INGN - Company Net Income|Expected Profit Inogen, Inc.|INGN - Price to Earnings Ratio|Future Price to Earnings Multiple inogen.com|INGN - PEG Multiple|Company Value to EBITDA Inogen Medical|INGN - Profit before payment of interest, taxes and amortization|Net earnings per share for the trailing year Inogen, Inc.|INGN - Net earnings per share for the last 12 months|Quarterly EPS earnings growth inogen.com|INGN - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Inogen, Inc.
- total revenue and sales volume data:
INGN - Company Revenue|Company Expected Revenue inogen.com|INGN - Price-to-Revenue Ratio|Forward Price-to-Revenue Multiple Inogen Medical
General company analysis:INGN, Inogen Inc
Mass-produced product of Inogen Inc

The P/S multiple determines the market value of Inogen, Inc. (INGN) relative to its annual sales volume, allowing investors to assess the premium paid for each unit of revenue. When analyzing changes in the P/S multiple, it should be noted that the current capitalization reflects market expectations regarding the implementation of robotic assembly and the scaling of predictive cloud software for equipment health monitoring.

Competing companies

P/S Multiple stryker.com (SYK)|Price-to-Revenue Ratio Medtronic MDT|Price-to-Revenue Coefficient Royal Philips (PHG)|SNN: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio HOLX (Hologic Medical)|Carlisle Companies (CSL) - Price-to-Revenue Ratio|Market Cap to Revenue integer.net|LIVN (LivaNova) - P/S Multiple|Price to Sales AdaptHealth Corp AHCO|P/S Multiple SSII|Avanos Corp - Market Cap to Revenue Ratio|P/S Multiple SI (Shoulder Innovations)|Price-to-Revenue Coefficient viemed.com (VMD)|Owlet Care - P/S Multiple|Quipt Home Medical Corp (QIPT) - Market Cap to Revenue|POCI: P/S Multiple|PAVmed (PAVM) - P/S Multiple|Price-to-Revenue Ratio Tivic Health Systems|Price-to-Revenue Ratio MOVE|Market Cap to Revenue NUVO (Nuvo Group)